A retrospective study of red cell maternal antibodies by chemiluminescence

Vox Sanguinis

Volumn 71, Issue 4, 1996, Pages 226-232

  Downing, I ^a,c   Bromilow, I M ^b   Templeton, J G ^a   Fraser, R H ^a  

^a Glasgow W Scotland Blood T   (United Kingdom)

^b Mersey and N Wales Transfus Centre   (United Kingdom)

^c Law Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ERYTHROCYTE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; MATERNAL ANTIBODY;

ARTICLE; BLOOD TRANSFUSION; CHEMOLUMINESCENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; MONOCYTE; NEWBORN HEMOLYTIC DISEASE; NORMAL HUMAN; PHOTOTHERAPY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0029911290     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1997.73100546_71_4.x     Document Type: Article

References (30)

1. Bowman JM: Haemolytic disease of the newborn. Baillières Clin Immunol Allergy 1987; 1/2:391-425.
2. Nicolaides KH, Rodeck CH: Maternal serum anti-D antibody, concentration and assessment of rhesus isoimmunisation. Br Med J 1992;304: 1155.
3. Morley G, Gibson M, Eltringhham D: Use of discriminant analysis in relating maternal anti-D levels to the severity of haemolytic disease of the newborn. Vox Sang 1977;32:90-98.
4. Nicolaides KH, Rodeck CH, Mibashan RS: Obstetric management and diagnosis of haematological disease in the fetus. Clin Haematol 1985;14:775-805.
5. Contreras M: Antenatal tests in the diagnosis and assessment of severity of haemolytic disease (HD) of the fetus and newborn (HDN). Vox Sang 1994;67:207-209.
6. Nance SJ, Arndt P, Garratty G: Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449-452.
7. Urbaniak SJ, Griess MA, Crawford RJ, Fergusson MJC: Prediction of the outcome of rhesus haemolytic disease of the newborn: Additional information using an ADCC assay. Vox Sang 1984;46:323-329.
8. Downing I, Templeton JG, Mitchell R, Fraser RH: A chemiluminescence assay for erythrophagocytosis. J Biolumin Chemilumin 1990;6: 243-250.
9. Hadley AG, Kumpel BM, Leader KA, Poole GD, Fraser IB: Correlation of serological, quantitative and cell mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn. Br J Haematol 1991;77:221-228.
10. Gunson HH, Phillips PK, Stratton F: Manipulative and inherent errors in anti-D quantification using the AutoAnalyzer. J Clin Pathol 1972;25: 198-205.
11. Schanfield MS, Schoeppner SL, Stevens JO: New approaches to detecting clinically significant antibodies in the laboratory; in Sandler SG, Nusbacher J, Schanfield MS (eds): Immunobiology of the Erythrocyte. New York, Liss 1980, pp 305-323.
12. Kumpel BL: A simple non-isotopic method for the quantification of red cell bound immunoglobulin. Vox Sang 1990;59:34-38.
13. Olson PR, Weiblen BJ, O'Leary JJ, Moscowity AJ, McCullough J: A simple technique for the inactivation of IgM antibodies using dithiothreitol. Vox Sang 1976;30:149-159.
14. Hadley AG, Garner SF, Taverner JM: AutoAnalyzer quantification, monocyte-mediated cytotoxicity and chemiluminescence assays for predicting the severity of haemolytic disease of the newborn.Tranfus Med 1993;3:195-200.
15. + cells. Immunology 1990;72:481-483.
16. Hadley AG, Poole GD, Amphlett NW, Lucas GF: The use of interferon-γ-treated U937 cells in chemiluminescence assays to detect red cell, platelet and granulocyte antibodies of potential clinical significance. Clin Lab Haematol 1992; 14:315-326.
17. Bennet PR, Le Van Kim C, Colin Y, Warwick RM, Cherif-Zahar B, Fisk N, Cartron JP: Prenatal deterioration of fetal RhD type by DNA amplification. N Engl J Med 1993;329:607-610.
18. Nelson M, Forsyth C, Popp H, Gibson J: Rapid detection of RhD or K positive fetal red cells in chorion villus samples by a flow cytometric technique. Transfus Med 1994;4:297-302.
19. Garner SF, Niener E, Contreras M, Nicolini U, Kochenour N, Letsky E, Rodeck H: Mononuclear phagocyte assays, AutoAnalyzer quantitation and IgG subclasses of maternal anti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation. Br J Haematol 1992;80:97-101.
20. Bowell P, Wainscoat JS, Peto TEA, Gunson HH: Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn. Br Med J 1982;285:327-329.
21. Hughes-Jones NC, Ivona M, Ellis J, Walker W: Anti-D concentration in mother and child in haemolytic disease of the newborn. Vox Sang 1971;1:135-140.
22. Hadley AG, Kumpel BM, Merry AH: The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-RhD antibodies. Clin Lab Haematol 1988; 10:377-384.
23. Koylowski CL, Lee D, Shwe KH, Love EM: Quantification of anti-c in haemolytic disease of the newborn. Transfus Med 1995;5:37-42.
24. Wiener E, Jolliffe VN, Scott HCF, Kumpel BM, Thompson KM, Melamed MD, Hughes-Jones NC: Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes. Immunology 1988;65:159-163.
25. Lucas GF, Hadley AG, Nance SJ, Garratty G: Predicting haemolytic disease of the newborn: A comparison of the monocyte monolayer assay and the chemiluminescence test. Transfusion 1993;33:484-487.
26. Engelfriet CP, Overbeeke MAM, Dooren MC, Ouwehand WH, Kr Von Dem Borne AEG: Bioassays to determine the clinical significance of red cell allo-antibodies based on Fc receptor-induced destruction of red cells sensitized by IgG. Transfusion 1994;34:617-626.
27. Pollock JM, Bowman JM: Anti-RhD IgG subclasses and severity of Rh haemolytic disease of the newborn. Vox Sang 1990;59:176-179.
28. Lubenko A, Contreras M, Rodeck CH, Nicolini U, Savage J, Chana H: Transplancental IgG subclass concentrations in pregnancies at risk of haemolytic disease of the newborn. Vox Sang 1994;67:291-298.
29. Zupanska B, Brojer E, Richards Y, Lenkiewicz B, Seyfried H, Howell P: Serological and immunological characteristics of maternal anti-Rh (D) antibodies in predicting the severity of haemolytic disease of the newborn. Vox Sang 1989; 56:247-253.
30. Van Dijk BA, Dooren MC, Overbeeke MAM: Red cell antibodies in pregnancy: There is no 'critical titre'. Transfus Med 1995;45:199-202.